During the past decade, Millennium Oncology Research Clinic conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Millennium Oncology Research Clinic" #1 collaborator was "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Millennium Oncology Research Clinic" are "Multiple Myeloma" (2 trials), "Neoplasm Metastasis" (2 trials), "Abiraterone Acetate" (1 trials), "Androgens" (1 trials) and "Antineoplastic Agents" (1 trials). Many other conditions were trialed in "Millennium Oncology Research Clinic" in a lesser frequency.

Most popular intervention types in "Millennium Oncology Research Clinic" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (2 trials), "Abiraterone" (1 trials), "Anastrozole" (1 trials), "Carfilzomib" (1 trials) and "Dexamethasone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Millennium Oncology Research Clinic" are 4 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Millennium Oncology Research Clinic". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Millennium Oncology Research Clinic, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Millennium Oncology Research Clinic, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".